BP’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-2,429
| Closed | -$1.36M | – | 422 |
|
2021
Q2 | $1.36M | Sell |
2,429
-1,018
| -30% | -$569K | 0.06% | 188 |
|
2021
Q1 | $1.63M | Sell |
3,447
-900
| -21% | -$426K | 0.06% | 192 |
|
2020
Q4 | $2.1M | Sell |
4,347
-4,053
| -48% | -$1.96M | 0.06% | 180 |
|
2020
Q3 | $4.7M | Sell |
8,400
-700
| -8% | -$391K | 0.11% | 153 |
|
2020
Q2 | $5.67M | Buy |
9,100
+1,100
| +14% | +$685K | 0.21% | 110 |
|
2020
Q1 | $3.91M | Hold |
8,000
| – | – | 0.17% | 142 |
|
2019
Q4 | $3M | Hold |
8,000
| – | – | 0.1% | 218 |
|
2019
Q3 | $2.22M | Hold |
8,000
| – | – | 0.08% | 263 |
|
2019
Q2 | $2.5M | Sell |
8,000
-600
| -7% | -$188K | 0.09% | 246 |
|
2019
Q1 | $3.53M | Hold |
8,600
| – | – | 0.14% | 179 |
|
2018
Q4 | $3.21M | Sell |
8,600
-1,400
| -14% | -$523K | 0.13% | 179 |
|
2018
Q3 | $4.04M | Buy |
10,000
+1,000
| +11% | +$404K | 0.12% | 194 |
|
2018
Q2 | $3.11M | Hold |
9,000
| – | – | 0.1% | 225 |
|
2018
Q1 | $3.1M | Hold |
9,000
| – | – | 0.11% | 220 |
|
2017
Q4 | $3.38M | Sell |
9,000
-1,000
| -10% | -$376K | 0.12% | 213 |
|
2017
Q3 | $4.47M | Hold |
10,000
| – | – | 0.16% | 171 |
|
2017
Q2 | $4.91M | Hold |
10,000
| – | – | 0.18% | 159 |
|
2017
Q1 | $3.87M | Hold |
10,000
| – | – | 0.15% | 177 |
|
2016
Q4 | $3.67M | Hold |
10,000
| – | – | 0.14% | 192 |
|
2016
Q3 | $4.02M | Buy |
+10,000
| New | +$4.02M | 0.16% | 177 |
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$2.71M | – | 326 |
|
2015
Q4 | $2.71M | Hold |
5,000
| – | – | 0.11% | 220 |
|
2015
Q3 | $2.32M | Sell |
5,000
-6,000
| -55% | -$2.78M | 0.1% | 220 |
|
2015
Q2 | $5.61M | Hold |
11,000
| – | – | 0.21% | 152 |
|
2015
Q1 | $4.97M | Sell |
11,000
-3,000
| -21% | -$1.35M | 0.16% | 176 |
|
2014
Q4 | $5.74M | Buy |
+14,000
| New | +$5.74M | 0.15% | 164 |
|